These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34589438)

  • 21. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
    Ling DC; Vargo JA; Glaser SM; Kim H; Beriwal S
    Gynecol Oncol; 2019 Mar; 152(3):581-586. PubMed ID: 30600093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
    Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
    Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
    Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
    Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ; Chu C; Rubin S; Lin LL
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Case Selection for Vaginal Cuff Brachytherapy in Cervical Cancer Patients After Radical Hysterectomy and External Beam Radiation Therapy.
    Lai YL; Jin YN; Wang X; Qi WX; Cai R; Xu HP
    Front Oncol; 2021; 11():685972. PubMed ID: 34249734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-year review of radiotherapy for vaginal cancer: an institutional experience.
    Lian J; Dundas G; Carlone M; Ghosh S; Pearcey R
    Gynecol Oncol; 2008 Nov; 111(2):298-306. PubMed ID: 18722657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery followed by concurrent radiochemotherapy as treatment for patients with locally recurrent cervical cancer.
    Zhang X; Chen Z; Chen J; Wang J; Wang Y; Zhu J
    Transl Cancer Res; 2021 Oct; 10(10):4365-4374. PubMed ID: 35116295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
    Kim HJ; Chang JS; Koom WS; Lee KC; Kim GE; Kim YB
    Gynecol Oncol; 2018 Nov; 151(2):208-214. PubMed ID: 30195468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status.
    Alban G; Cheng T; Adleman J; Buzurovic I; Pretz J; Singer L; King M; Lee L
    Int J Gynecol Cancer; 2021 Jul; 31(7):1007-1013. PubMed ID: 33858956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
    Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
    Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
    Lee LJ; Damato AL; Viswanathan AN
    Gynecol Oncol; 2013 Dec; 131(3):586-92. PubMed ID: 24029418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.
    Qu A; Jiang P; Sun H; Jiang W; Jiang Y; Tian S; Wang J
    J Gynecol Oncol; 2019 Jan; 30(1):e9. PubMed ID: 30479093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer.
    Morgenthaler J; Köhler C; Budach V; Sehouli J; Stromberger C; Besserer A; Trommer M; Baues C; Marnitz S
    Strahlenther Onkol; 2021 Jun; 197(6):474-486. PubMed ID: 32970164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.
    Lin LL; Grigsby PW; Powell MA; Mutch DG
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):500-4. PubMed ID: 16168841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
    Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
    Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.